Aldeyra Therapeutics, Inc. (ALDX)
4.99
+0.24
(+5.05%)
USD |
NASDAQ |
Jan 21, 16:00
4.975
-0.02
(-0.30%)
After-Hours: 20:00
Aldeyra Therapeutics Free Cash Flow: -40.08M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals, Inc. | -82.95M |
| ADMA Biologics, Inc. | 40.61M |
| Exelixis, Inc. | 779.77M |
| Altimmune, Inc. | -66.66M |
| Actinium Pharmaceuticals, Inc. | -25.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.021M |
| Cash from Investing (Quarterly) | 25.00M |
| Cash from Financing (Quarterly) | 0.1207M |
| Free Cash Flow Per Share (Quarterly) | -0.1168 |
| Free Cash Flow to Equity (Quarterly) | -7.009M |
| Free Cash Flow to Firm (Quarterly) | -6.546M |
| Free Cash Flow Yield | -13.41% |